Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - Re: Pacer T2: TPL's Motion for Continuance 12-12-12

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Back To Forum List View

Pacer T2: TPL's Motion for Continuance 12-12-12

BaNosser

Dec 12, 2012 09:17PM

Re: Pacer T2: TPL's Motion for Continuance 12-12-12

emit

Dec 12, 2012 09:22PM

Re: Pacer T2: TPL's Motion for Continuance 12-12-12

Billbow

Dec 12, 2012 09:29PM

BaNosser

Rank: President [?]

Points: 24217 [?]

Votes: 157 Score: 3.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Pacer T2: TPL's Motion for Continuance 12-12-12

in response to

Re: Pacer T2: TPL's Motion for Continuance 12-12-12

emit

posted on Dec 12, 2012 09:30PM

It appears to this layman, that TPL is saying 'we're ready to go to trial', but it can't conflict with ITC... Perhaps upon the long version of the Claim Construction they may be more inclined to drasft a MSJ...

If we can't get a MSJ.. I think trial is next best thing...

HTC trying to reopen the Claim Construction.... SCREW YOU

pardon my Spanish..

8 Recommendations

Re: Pacer T2: TPL's Motion for Continuance 12-12-12

BaNosser

Dec 12, 2012 09:33PM

Re: Pacer T2: TPL's Motion for Continuance 12-12-12

JimmyBond

Dec 12, 2012 09:49PM

Re: Pacer T2: TPL's Motion for Continuance 12-12-12

StillinAustin